发明名称 Ethanolamine compounds.
摘要 <p>The invention provides compounds of the general formula (I) &lt;CHEM&gt; wherein Ar represents a phenyl group optionally substituted by one or more substituents selected from halogen atoms, or the groups C1-6 alkyl, nitro, -(CH2)qR, [where R is hydroxy, C1-6 alkoxy, -NR&lt;3&gt;R&lt;4&gt; (where R&lt;3&gt; and R&lt;4&gt; each represents a hydrogen atom, or a C1-4 alkyl group, or -NR&lt;3&gt;R&lt;4&gt; forms a saturated heterocyclic amino group which has 5-7 ring members and optionally contains in the ring one or more atoms selected from -O- or -S- or a group -NH- or -N(CH3)-), -NR&lt;5&gt;COR&lt;6&gt; (where R&lt;6&gt; represents a hydrogen atom or a C1-4 alkyl group, and R&lt;6&gt; represents a hydrogen atom or a C1-4 alkyl, C1-4 alkoxy, phenyl or -NR&lt;3&gt;R&lt;4&gt; group), -NR&lt;5&gt;SO2R&lt;7&gt; (where R&lt;7&gt; represents a C1-4 alkyl, phenyl or -NR&lt;3&gt;R&lt;4&gt; group), -COR&lt;8&gt; (where R&lt;8&gt; represents hydroxy, C1-4 alkoxy or -NR&lt;3&gt;R&lt;4&gt;), -SR&lt;9&gt; (where R&lt;9&gt; is a hydrogen atom, or a C1-4 alkyl or phenyl group), -SOR&lt;9&gt;, -SO2R&lt;9&gt;, or -CN, and q represents an integer from 0 to 3], or -O(CH2tR&lt;1&gt;&lt;1&gt; [where R&lt;1&gt;&lt;1&gt; represents a hydroxy or C1-4 alkoxy group and t is 2 or 3], or Ar is a phenyl group substituted by an alkylenedioxy group of formula -O(CH2)pO-, where p represents 1 or 2; R&lt;1&gt; and R&lt;2&gt; each represent a hydrogen atom or a C1-3 alkyl group, with the proviso that the sum total of carbon atoms in R&lt;1&gt; and R&lt;2&gt; is not more than 4; R&lt;2&gt;&lt;0&gt; represents a C1-3 alkyl group; X represents a C2-8 alkylene C2-8 alkenylene or C2-8 alkynylene chain, and Y represents a C1-7 alkylene C2-7 alkenylene or C2-7 alkynylene chain, with the proviso that the sum total of carbon atoms in X and Y is 4 to 12; Q represents (a) &lt;CHEM&gt; (where R&lt;1&gt;&lt;2&gt; is a straight or branched C1-3 alkylene group), &lt;CHEM&gt; (where one of R&lt;1&gt;&lt;3&gt; and R&lt;1&gt;&lt;4&gt; is a hydroxy group and the other is a hydrogen or halogen atom or a hydroxy group), &lt;CHEM&gt; [where R&lt;1&gt;&lt;5&gt; is a group R&lt;1&gt;&lt;6&gt;CO-, R&lt;1&gt;&lt;6&gt;NHCO-, R&lt;1&gt;&lt;6&gt;R&lt;1&gt;&lt;7&gt;NSO2- or R&lt;1&gt;&lt;8&gt;SO2- (where R&lt;1&gt;&lt;6&gt; and R&lt;1&gt;&lt;7&gt; is each a hydrogen atom or a C1-3 alkyl group and R&lt;1&gt;&lt;8&gt; is a C1-3 alkyl group) and p is an integer 0 or 1], &lt;CHEM&gt; (where R&lt;2&gt;&lt;6&gt; and R&lt;2&gt;&lt;7&gt; is each a hydrogen atom or a C1-3 alkyl group or, when R&lt;2&gt;&lt;6&gt; is a hydrogen atom, R&lt;2&gt;&lt;7&gt; may also be a C1-4 alkoxycarbonyl group), &lt;CHEM&gt; (where R&lt;1&gt;&lt;9&gt; is a C1-3 alkyl group), &lt;CHEM&gt; and physiologically acceptable salts and solvates (e.g. hydrates) thereof. The compounds have a stimulant action at beta 2-adrenoreceptors and may be used in the treatment of diseases associated with reversible airways obstruction such as asthma and chronic bronchitis.</p>
申请公布号 EP0220878(A2) 申请公布日期 1987.05.06
申请号 EP19860307975 申请日期 1986.10.15
申请人 GLAXO GROUP LIMITED 发明人 FINCH, HARRY;NAYLOR, ALAN;LUNTS, LAWRENCE HENRY CHARLES;SKIDMORE, IAN FREDERICK
分类号 A61K31/135;A61K31/165;A61K31/17;A61K31/19;A61K31/215;A61K31/275;A61K31/357;A61K31/36;A61K31/44;A61P25/02;C07C67/00;C07C213/00;C07C217/10;C07C231/00;C07C231/12;C07C233/25;C07C233/36;C07C233/43;C07C233/75;C07C235/42;C07C239/00;C07C253/00;C07C255/37;C07C255/54;C07C255/59;C07C271/16;C07C275/32;C07C301/00;C07C303/34;C07C303/40;C07C311/00;C07C313/00;C07C313/04;C07C313/12;C07C313/16;C07C317/22;C07C317/28;C07C323/12;C07C323/14;C07D213/65;C07D325/00;(IPC1-7):C07C93/08;C07C93/14;C07C93/10 主分类号 A61K31/135
代理机构 代理人
主权项
地址
您可能感兴趣的专利